FAMILY ID 21 CRC: Colorectal cancer LC: Lung cancer LGR: c.212-?_366+?del I:1I:2 CRC II:1 CRC II:2 CRC II:3 LC II:4II:5 III:2III:3 II:6 III:4III:5III:6.

Slides:



Advertisements
Similar presentations
Lynch Syndrome and Colorectal Cancer Steven G. Proshan, M.D. Annapolis Colon and Rectal Surgeons Anne Arundel Medical Center November 8,
Advertisements

A few thoughts on cancer and cancer family syndromes Pamela McGrann, MD. Department of Medical Genetics.
Morning Report May 20, 2009 Bridger Clarke  Born in Lawrence, Massachusetts, on 4 January  Dropped out of high school at the age of fourteen.
1 Financial Mathematics Clicker review session, Final.
What is the role of free PSA? Total PSA Range 2.5 to 4.0 ng/ml Age Range (Years) %Free PSA=60 (yrs)All Ages
I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=
I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=
By: Ashleen Atchue and Mario Tovar
High risk population in GI field how we can find them? Ahmad Shavakhi MD Associate professor of gastroenterology.
CONFIDENTIAL PillCam ™ COLON PillCam™ COLON has received a CE Mark, but is not cleared for marketing or available for commercial distribution in the USA.
8.1.4 Can it still be factored? Factoring Completely I can factor out a common factor.
Cancer “whiteboard” presentation ●Name of cancer (what type), where can it occur? ●Function of body part that it affects ●Causes (genetic, environmental…)?
FRENCH high-resolution studies - Breast cancer: 1990, 1997, 2003, 2010 ? - Colorectal cancer: 1990, 1995, 2000, 2005, 2010 ? - Prostate cancer: 1995,
Translational and Personalized Medicine Initiative: Quality of Care Project Report.
基 督 再 來 (一). 經文: 1 你們心裡不要憂愁;你們信神,也當信我。 2 在我父的家裡有許多住處;若是沒有,我就早 已告訴你們了。我去原是為你們預備地去 。 3 我 若去為你們預備了地方,就必再來接你們到我那 裡去,我在 那裡,叫你們也在那裡, ] ( 約 14 : 1-3)
LESSON 14.3 “Cancer”. Cancer: a group of diseases in which cells divide in an uncontrolled manner. Not contagious Not caused by injury Causes are not.
Cancer Facts MS JYOTI SHAH CONSULTANT UROLOGICAL SURGEON SOURCE: CANCER RESEARCH UK.
ΟΡΓΑΝΩΣΗ ΚΑΙ ΔΙΟΙΚΗΣΗ ΕΠΙΧΕΙΡΗΣΕΩΝ 3 Ο ΜΑΘΗΜΑ. ΟΙ ΜΕΓΑΛΕΣ ΕΠΙΧΕΙΡΗΣΕΙΣ Η δημιουργία μεγάλων επιχειρήσεων είναι ένα από τα χαρακτηριστικά του 20 ου αιώνα.
Qualified Patient Criteria Combinations (Female and Male) Personal History of (any one of the below): Breast or Ovarian cancer (any age) Prostate or Pancreatic.
Within the Cancer Program in MUH doing the best research and providing the best care to our patients. This is the best cancer care hospital.cancer care.
2 Incidence SABER This module presents statistics from Chapter 2: Incidence Ontario Cancer Statistics 2016 Chapter 2: Incidence.
The global medical imaging reagents market was valued at $10
Cancer.
5 Prevalence ZEINAB This module presents statistics from Chapter 5: Prevalence Ontario Cancer Statistics 2016 Chapter 5: Prevalence.
Figure 1. Overall survival of patients receiving alternative medicine (solid lines) vs conventional cancer treatment (dashed lines). Overall survival of.
Oncology for Family Medicine Residents:
Hereditary Gastrointestinal Cancers
The Perfect Marriage! Ephesians 5:21-33.
Glioblastoma Multiforme SSEA1+ CD133+
I'.II'.I. I I I - - -
Supplementary Figures
A Paradigm Shift From One-Size-Fits-All to Tailor-Made Therapy for Metastatic Colorectal Cancer.
4 Relative survival Ontario Cancer Statistics 2016 Chapter 4: Relative survival.
ФОНД ЗА РАЗВОЈ РЕПУБЛИКЕ СРБИЈЕ
1.
تهیه کننده: استاد مربوطه: بهار 1392
Pedigrees of families found to carry mutations in RINT1 via WES
5 Prevalence Ontario Cancer Statistics 2016 Chapter 5: Prevalence.
Слайд-дәріс Қарағанды мемлекеттік техникалық университеті
.. -"""--..J '. / /I/I =---=-- -, _ --, _ = :;:.
n --- IiIi.
/ / 'III '- Ei 'ltWtilw I' :&:& 1:1 1:1: - 1 I 0.
Estimated current cancer incidence
.... j,j, I, J a '. 111 II IlI l J _, - __f"' c:
Association of Family History of Specific Cancers With a Younger Age of Onset of Pancreatic Adenocarcinoma  Robert R. McWilliams, William R. Bamlet, Kari.
Lung Cancer (C33-C34): Number and Proportion of Cases Diagnosed at Each Stage, Adults 15-99, Former Anglia Cancer Network Percentage of Total.
II //II // \ Others Q.
Как да кандидатстваме по НИФ
ОПЕРАТИВНА ПРОГРАМА “ИНОВАЦИИ И КОНКУРЕНТОСПОСОБНОСТ“ „Подобряване на производствения капацитет в МСП“
ВОМР Подмярка 19.2 Възможности за финансиране
Споразумение за партньорство
'III \-\- I ', I ,, - -
I1I1 a 1·1,.,.,,I.,,I · I 1··n I J,-·
Clinical applications of CTCs and ctDNA as liquid biopsy for personalized medicine. Clinical applications of CTCs and ctDNA as liquid biopsy for personalized.
A Combined Prognostic Serum Interleukin-8 and Interleukin-6 Classifier for Stage 1 Lung Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening.
R 1.1 t' r'. ').. "'. I{III{II \I\I ' IIII t J I I f c t -
Waterfall plots of the best per cent change from baseline in sum of longest diameters (SLD) for target lesions. Waterfall plots of the best per cent change.
Solving Equations 3x+7 –7 13 –7 =.
Volume 128, Issue 5, Pages (May 2005)
Literature Flow to Assess the Effects of Omega-3 Fatty Acid on Tumor Incidence Catherine H. MacLean, et al, JAMA. 2006; 295:
Example Make x the subject of the formula
Phosphorylation of TRIO Y2681 in human colorectal cancer (CRC) is correlated with poorer prognosis. Phosphorylation of TRIO Y2681 in human colorectal cancer.
,, 'III \-\-
' · · ,.-.., '' !'",. -,..._ ·-.·-...;.· -
. '. '. I;.,, - - "!' - -·-·,Ii '.....,,......, -,
Lung Cancer (C33-C34): 2011 Proportion of Cases Diagnosed at Each Stage, Adults (Aged 15-99), England and Wales Stage Adults Stage I 14.5% Stage II 7.3%
Overview of cancer genetics in the SMP1 cohort: lung cancer (A), breast cancer (B), colorectal adenocarcinoma (except mucinous subtype) (C), prostate cancer.
Survival in patients with colorectal cancer diagnosed by screening colonoscopy  Kilian Friedrich, MD, Ludwig Grüter, MD, Daniel Gotthardt, MD, PhD, Christoph.
U A B II III I IV 94.
Presentation transcript:

FAMILY ID 21 CRC: Colorectal cancer LC: Lung cancer LGR: c.212-?_366+?del I:1I:2 CRC II:1 CRC II:2 CRC II:3 LC II:4II:5 III:2III:3 II:6 III:4III:5III:6 IV:1IV:2 III:1 CRC 45y +/- year 1999

FAMILY ID 65 CRC: Colorectal cancer A: Villous Adenoma EC: Endometrial cancer LGR: arr 2p21 ( )x3 year 2001

FAMILY ID 104 CRC: Colorectal cancer UC: Urothilial cancer EC: Endometrial cancer PC: Pancreatic cancer LC: Laryngeal cancer LGR: g del4457 CRC year 2003

FAMILY ID 141 CRC: Colorectal cancer LGR: g del year 2003 CCR 31y +/-

FAMILY ID 481 II:1 CRC 43y +/- II:2 54y -/- III:1 CRC 33y +/- III:2 29y +/- III:3III:4 17y -/- I:1 CRC I:2 BC II:3 CRC II:4II:5II:6II:7 III:5 II:8 III:6III:7III:8 CRC: Colorectal cancer LGR: 2p21 ( )x3, g del2471, 2p21 ( )x3 year 2007

FAMILY ID 499 IV:1 27y +/- IV:2 CRC: Colorectal cancer OC: Ovarian cancer EC: Endometrial cancer LGR: g del76839 II:8 y III:14: these patients have been studied recently year 2007

FAMILY ID 537 CRC: Colorectal cancer EC: Endometrial cancer DC: Duodenal cancer LGR: g del8280, 10q23.31( )x1 IV:8: this patient has been studied recently year 2008

FAMILY ID 639 II:1 CRC UC 64y +/- II:2 BoC III:1 CRC 35y +/- III:2 39y +/- III:3 37y +/- III:6III:7III:8 IV:1IV:2 III:9 IV:3IV:4 I:1 GC I:2 II:3 LC CRC: Colorectal cancer UC: Urothilial cancer LC: Liver cancer BoC: Bone cancer LGR: arr 2p21 ( )x3 year 2008

EC CCR 46y +/- CRC: Colorectal cancer UC: Urothilial cancer LC: Lung Cancer L: Lymphoma PC: Prostate cancer LGR: EPCAM c.859-? _904+?del + MSH2 c.1-?_1076+?del FAMILY ID 677 year 2011